
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.
EpiCor, the immune-balancing ingredient from Embria Health Sciences (Ankeny, IA), has received New Dietary Ingredient (NDI) notification from the FDA, the company reports.
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.






